Results 261 to 270 of about 466,155 (352)

Decreased vascular responsiveness produced by angiotensin-converting enzyme inhibitors in the rat isolated kidney.

, 1982
Satoru Chiba, C P Quilley, J C McGiff
openalex  

Transient angiotensin-converting enzyme inhibition confers sex-specific protection against angiotensin II-induced cardiac remodeling. [PDF]

Am J Physiol Cell Physiol
Garvin AM, Floyd DB, Bailey AC, Lindsey ML, Carroll CC, Hale TM.   +5 more
europepmc   +1 more source

Hemodynamic and antihypertensive effects of the new oral angiotensin-converting-enzyme inhibitor MK-421 (enalapril).

, 1984
F. M. Fouad, Robert C. Tarazi, E L Bravo, Stephen C. Textor   +3 more
openalex   +1 more source

Another Crohn's Disease Mimicker: A Case of Angiotensin-Converting Enzyme Inhibitor-Induced Intestinal Angioedema. [PDF]

ACG Case Rep J
Adam M, Tselovalnikova T, Evans A.
europepmc   +1 more source

Molecular insights into the inhibition of angiotensin-converting enzyme 1 by hemopressin peptides. [PDF]

Sci Rep
Antony P, Baby B, Rahma A, Samad SA, Dhaheri YA, Vijayan R.   +5 more
europepmc   +1 more source

Renal and adrenal responses to hypoxemia during angiotensin-converting enzyme inhibition in lambs.

, 1983
D Weismann, James Herrig, O. J. McWeeny, Nancy A. Ayres, J Robillard   +4 more
openalex   +1 more source

Increased Cerebrospinal Fluid Angiotensin-Converting Enzyme 2 Fragments as a Read-Out of Brain Infection in Patients With COVID-19 Encephalopathy. [PDF]

J Infect Dis
Lennol MP, García-Ayllón MS, Avilés-Granados C, Trasciatti C, Tolassi C, Quaresima V, Arici D, Cristillo V, Volonghi I, Caprioli F, De Giuli V, Mariotto S, Ferrari S, Zanusso G, Ashton NJ, Zetterberg H, Blennow K, Padovani A, Pilotto A, Sáez-Valero J.   +19 more
europepmc   +1 more source

Radiotracers for Molecular Imaging of Angiotensin-Converting Enzyme 2. [PDF]

Int J Mol Sci
Xu W, Langhans SA, Johnson DK, Stauff E, Kandula VVR, Kecskemethy HH, Averill LW, Yue X.   +7 more
europepmc   +1 more source

Studies on angiotensin converting enzyme inhibitors. III. 2-Carboxyethylcarbamoyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives.

, 1985
Kimiaki Hayashi, K. NUNAMI, Kazuo Sakai, Yasuhiko Ozaki, Jyoji Kato, KEIZO KINASHI, N. YONEDA   +6 more
openalex   +2 more sources

Design of Novel Mercapto-3-phenylpropanoyl Dipeptides as Dual Angiotensin-Converting Enzyme C-Domain-Selective/Neprilysin Inhibitors. [PDF]

J Med Chem
Cozier GE, Coulson LB, Eyermann CJ, Basarab GS, Schwager SL, Chibale K, Sturrock ED, Acharya KR.   +7 more
europepmc   +1 more source